Literature DB >> 17581232

Promises of biomarkers in drug development--a reality check.

Estelle Marrer1, Frank Dieterle.   

Abstract

Biomarkers have been a buzz word in drug development for the last 5 years. But where do we stand now? This perspective article will demonstrate to which extent biomarkers have impacted drug development and the use of drugs. In particular, the different types of biomarkers, their identification, validation and use in different phases of drug development from drug discovery, to approval, to clinical application will be discussed as well as the state-of-the-art biomarker technologies and promising future methods. The high interest in biomarkers has generated the need for development of new technologies and refinement of existing ones. Besides discussing their perspectives of applications, the present article also illustrates the future of biomarker development in terms of qualification for regulatory use and co-development.

Mesh:

Substances:

Year:  2007        PMID: 17581232     DOI: 10.1111/j.1747-0285.2007.00522.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  15 in total

1.  Research at the interface of industry, academia and regulatory science.

Authors:  William B Mattes; Elizabeth Gribble Walker; Eric Abadie; Frank D Sistare; Jacky Vonderscher; Janet Woodcock; Raymond L Woosley
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders.

Authors:  Willard M Freeman; Kent E Vrana
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

Review 3.  Proteomics and biomarkers in clinical trials for drug development.

Authors:  Jung-min Lee; Jasmine J Han; Gary Altwerger; Elise C Kohn
Journal:  J Proteomics       Date:  2011-05-04       Impact factor: 4.044

Review 4.  Novel opportunities for computational biology and sociology in drug discovery.

Authors:  Lixia Yao; James A Evans; Andrey Rzhetsky
Journal:  Trends Biotechnol       Date:  2010-04       Impact factor: 19.536

5.  Traversing the valley of death: a guide to assessing prospects for translational success.

Authors:  Barry S Coller; Robert M Califf
Journal:  Sci Transl Med       Date:  2009-12-09       Impact factor: 17.956

6.  Can Functional Magnetic Resonance Imaging Improve Success Rates in CNS Drug Discovery?

Authors:  David Borsook; Richard Hargreaves; Lino Becerra
Journal:  Expert Opin Drug Discov       Date:  2011-06-01       Impact factor: 6.098

Review 7.  Novel opportunities for computational biology and sociology in drug discovery.

Authors:  Lixia Yao; James A Evans; Andrey Rzhetsky
Journal:  Trends Biotechnol       Date:  2009-08-10       Impact factor: 19.536

Review 8.  Glial biomarkers in human central nervous system disease.

Authors:  Gwenn A Garden; Brian M Campbell
Journal:  Glia       Date:  2016-05-26       Impact factor: 7.452

Review 9.  From differentiating metabolites to biomarkers.

Authors:  Albert Koulman; Geoffrey A Lane; Scott J Harrison; Dietrich A Volmer
Journal:  Anal Bioanal Chem       Date:  2009-03-11       Impact factor: 4.142

10.  Using expression and genotype to predict drug response in yeast.

Authors:  Douglas M Ruderfer; David C Roberts; Stuart L Schreiber; Ethan O Perlstein; Leonid Kruglyak
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.